ClinicalTrials.gg
Not yet recruitingNCT07925918Updated Nov 9, 2026

In Elderly Patients, Does Goal-directed Fluid Management Using the Carotid Corrected Flow Time (CC-FT) Index, Compared to Routine Fluid Management, Affect the Occurrence of Post-induction Hypotension?

An interventional study of CC-FT Guided Fluid Management Group and Conventional Fluid Management Group in Hypotension (MeSH: D007022) and Aged, sponsored by Zhihong LU. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Zhihong LU · Not applicable, Interventional, and Prevention

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This study aims to find out whether using a simple ultrasound measurement of blood flow in the neck artery can help doctors decide how much fluid to give older patients before general anesthesia, and thereby reduce the drop in blood pressure that commonly occurs after anesthesia induction. Older adults are more likely to experience low blood pressure during anesthesia, and such drops have been linked to kidney injury, heart injury, and even death after surgery. Giving too little fluid can worsen organ blood supply, while giving too much can cause fluid overload, lung swelling, and heart strain. Currently, doctors often rely on static measures such as central venous pressure, or on invasive dynamic measures such as pulse pressure variation, but these have limited accuracy or require expensive equipment and invasive procedures. Carotid corrected flow time (FTc), measured non-invasively with ultrasound, reflects left ventricular preload and has shown promise for predicting fluid responsiveness, including in spontaneously breathing patients. However, evidence in older adults undergoing abdominal surgery remains limited to observational studies, and higher-level evidence from randomized trials is needed. We therefore plan a single-center, prospective, randomized, parallel-controlled trial in 70 patients aged 65 years or older scheduled for elective abdominal surgery under general anesthesia. Participants will be randomly assigned 1:1 to an FTc-guided prehydration group or a conventional fluid group. In the intervention group, if FTc falls below 340.7 ms, 250 mL of lactated Ringer's solution will be infused over 15 minutes, and FTc will be re-measured until it reaches at least 340.7 ms, in addition to a background infusion of 6 mL/kg/h started 30 minutes before induction. The control group will receive the same background infusion without FTc-guided adjustment. The primary outcome is the incidence of post-induction hypotension, defined as mean arterial pressure below 65 mmHg or a decrease of more than 20% from baseline within 15 minutes after induction. Secondary outcomes include the area under the curve of mean arterial pressure change from baseline during induction, intraoperative use of vasoactive agents, actual pre-induction fluid volume, postoperative pulmonary complications (pulmonary edema), acute kidney injury, myocardial injury, adverse events in the post-anesthesia care unit, time to first flatus and defecation, and all-cause mortality within 30 days after surgery.

Primary Hypothesis

Compared with conventional fluid management, carotid FTc-guided prehydration before anesthesia induction will reduce the incidence of post-induction hypotension in older patients undergoing elective abdominal surgery under general anesthesia.

02

Conditions studied

  • Hypotension (MeSH: D007022)
  • Aged

Browse trials for

Keywords

  • Post-induction hypotension
  • Carotid Corrected Flow Time
03

In context

Hypotension

885 studies on the registry are indexed under Hypotension; 195 are open to participants now.

This study's planned enrollment of 70 is below the median of 87 across 590 interventional studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Zhihong LU is the lead sponsor of 17 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age ≥ 65 years;

Scheduled for elective abdominal surgery under general anesthesia.

Exclusion criteria

Exclusion Criteria:

> III;

> 30 kg/m² or \< 18.5 kg/m²;

History of neck surgery or neck trauma;

History of peripheral arterial disease or arteriosclerosis, carotid artery stenosis exceeding one-third of the lumen, or significant anatomical variation of the carotid artery;

functional class > III;

History of cardiomyopathy or valvular heart disease;

Non-sinus rhythm;

Concomitant hypotension due to conditions such as septic shock;

Refusal to participate in the study.

Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    CC-FT Guided Fluid Management Group

    atients will receive fluid management guided by the Carotid Corrected Flow Time (CC-FT) index during anesthesia induction.

    Other: CC-FT Guided Fluid Management Group

  • Active comparator
    Conventional Fluid Management Group

    Patients will receive routine fluid management based on standard clinical parameters during anesthesia induction.

    Other: Conventional Fluid Management Group

Interventions

  • OtherCC-FT Guided Fluid Management Group

    Patients will receive fluid management guided by the Carotid Corrected Flow Time (CC-FT) index during anesthesia induction.

  • OtherConventional Fluid Management Group

    Patients will receive routine fluid management based on standard clinical parameters during anesthesia induction.

06

What researchers measure

Primary outcomes

  1. ncidence of post-induction hypotension

    Incidence of MAP \< 65 mmHg or a decrease of more than 20% from baseline

    Time frame: defined as within 15 minutes after induction

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925918
Lead sponsor
Zhihong LU
Responsible party
Zhihong LU (Associate Chief Physician, Department of Anesthesiology, Xijing Hospital, Air Force Medical University, Air Force Military Medical University, China) — Sponsor-investigator
First posted
Nov 9, 2026
Start date
Nov 25, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Zhihong LU Zhihong LU
Contact
deerlu23@163.com
86029-84775343

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion